These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35349827)

  • 1. T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.
    Venet F; Gossez M; Bidar F; Bodinier M; Coudereau R; Lukaszewicz AC; Tardiveau C; Brengel-Pesce K; Cheynet V; Cazalis MA; Pescarmona R; Garnier L; Ortillon M; Buisson M; Bouscambert-Duchamp M; Morfin-Sherpa F; Casalegno JS; Conti F; Rimmelé T; Argaud L; Cour M; Saadatian-Elahi M; Henaff L; Vanhems P; Monneret G;
    EBioMedicine; 2022 Apr; 78():103967. PubMed ID: 35349827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surviving Older Patients Show Preserved Cellular and Humoral Immunological Memory Several Months After SARS-CoV-2 Infection.
    García-Torre A; Bueno-García E; López-Martínez R; Rioseras B; Moro-García MA; Alonso-Alvarez S; Lluna-González A; Sousa-Fernández A; Fernández-Gudin M; Campos-Riopedre L; Castro-Del Cueto C; Pérez-Fernández AB; Alonso-Rodríguez A; Menéndez-Peña C; Menéndez-Peña L; García-Arnaldo N; Feito-Díaz E; Fernández-Lorences A; Fraile-Manzano A; Fernández-Iglesias C; Rivera JA; Pérez-Fonseca C; Urdiales-Ruano E; Debán-Fernández M; Mendes-Moreira H; Herrero-Puente P; Alonso-Arias R
    J Gerontol A Biol Sci Med Sci; 2022 Jan; 77(1):33-40. PubMed ID: 34252180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
    Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
    AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements.
    García-González P; Tempio F; Fuentes C; Merino C; Vargas L; Simon V; Ramirez-Pereira M; Rojas V; Tobar E; Landskron G; Araya JP; Navarrete M; Bastias C; Tordecilla R; Varas MA; Maturana P; Marcoleta AE; Allende ML; Naves R; Hermoso MA; Salazar-Onfray F; Lopez M; Bono MR; Osorio F
    Front Immunol; 2021; 12():769059. PubMed ID: 34745145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.
    Penttilä PA; Van Gassen S; Panovska D; Vanderbeke L; Van Herck Y; Quintelier K; Emmaneel A; Filtjens J; Malengier-Devlies B; Ahmadzadeh K; Van Mol P; Borràs DM; Antoranz A; Bosisio FM; Wauters E; Martinod K; Matthys P; Saeys Y; Garg AD; Wauters J; De Smet F;
    Cell Mol Life Sci; 2021 Apr; 78(8):3987-4002. PubMed ID: 33715015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.
    Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F
    J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
    Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
    Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.
    Miyara M; Saichi M; Sterlin D; Anna F; Marot S; Mathian A; Atif M; Quentric P; Mohr A; Claër L; Parizot C; Dorgham K; Yssel H; Fadlallah J; Chazal T; Haroche J; Luyt CE; Mayaux J; Beurton A; Benameur N; Boutolleau D; Burrel S; de Alba S; Mudumba S; Hockett R; Gunn C; Charneau P; Calvez V; Marcelin AG; Combes A; Demoule A; Amoura Z; Gorochov G
    Front Immunol; 2022; 13():790334. PubMed ID: 35222375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives.
    Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B
    Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
    Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent High Percentage of HLA-DR
    Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
    Front Immunol; 2021; 12():735125. PubMed ID: 34567001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
    Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ
    J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study.
    Torres-Ruiz J; Lomelín-Gascón J; Vargas-Castro AS; Lira-Luna J; Pérez-Fragoso A; Tapia-Conyer R; Nuñez-Aguirre M; Alcalá-Carmona B; Absalón-Aguilar A; Maravillas-Montero JL; Mejía-Domínguez NR; Núñez-Álvarez C; Rull-Gabayet M; Llorente L; Romero-Ramírez S; Sosa-Hernández VA; Cervantes-Díaz R; Juárez-Vega G; Meza-Sánchez DE; Martínez-Juárez LA; Morales-Juárez L; López-López LN; Negrete-Trujillo JA; Falcón-Lezama JA; Valdez-Vázquez RR; Gallardo-Rincón H; Gómez-Martín D
    Front Immunol; 2022; 13():943563. PubMed ID: 36045688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.